Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.4300
+0.0200 (4.88%)
Jul 10, 2026, 4:10 PM AEST
Nyrada Market Cap
Nyrada has a market cap or net worth of 105.33 million as of July 10, 2026. Its market cap has increased by 121.95% in one year.
Market Cap
105.33M
Enterprise Value
98.21M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.43
Market Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 105.33M, an increase of 309.76%. That is a compound annual growth rate of 24.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 105.33M | -61.34% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 142.66M |
| Alterity Therapeutics | 133.77M |
| Island Pharmaceuticals | 130.20M |
| Recce Pharmaceuticals | 112.30M |
| LTR Pharma | 103.61M |
| Paradigm Biopharmaceuticals | 89.33M |
| Avecho Biotechnology | 84.27M |
| Arovella Therapeutics | 79.78M |